“MICROBIOLOGICAL CONTROL AND MONITORING OF ASEPTIC PROCESSING ENVIRONMENTS & PRODUCT” Microbiologically controlled environments are used for a variety of purposes within the healthcare industry. This general information chapter provides information and recommendations for environments where the risk of microbial contamination is controlled through aseptic processing. Products manufactured in such environments include pharmaceutical sterile products, bulk sterile drug substances, sterile intermediates, excipients and in certain cases, medical devices. Aseptic processing environments are far more critical in terms of patient risk than controlled environments used for other manufacturing operations-for example, equipment and component preparation, limited bio-burden control of non-sterile products, and processing of terminally sterilized products. The type of aseptic processing is differentiated by the presence or absence of human operators. An advanced aseptic process is one in which direct intervention with open product containers or exposed product contact surfaces by operators wearing conventional clean-room garments is not required and never permitted. Clean rooms have a very special place and purpose in aseptic areas such as sterility lab. The establishment, maintenance, and control of the microbiological quality of the clean room and the controlled environments require engineering and science based approach. Aseptic area maintained by when microorganisms entry are prevented by providing high quality of air in the room, using HEPA (High Efficiency Particulate Air) filters that provide Laminar Air Flow. Surface monitoring of Walls and floor and equipments lying in class 10000 or Grade C shall be done by this method. Area of 100cm2 shall be selected for taking swabs. Swabs shall either be pre- sterilized or non sterile swabs can be sterilized at about 121 oC for 20 min or as per validation cycle. Sterilized swabs shall be placed in 10mL of sterile 0.9% saline solution. Rub the swab gently over the surface which is to be monitored. Keep them back in the tubes containing 0.9% saline solution. Each tube shall be marked with the location and date of sampling. Take 1mL of saline suspension containing swab sample in, pre sterilized Petri dish. Pour molten Soyabean casein digest agar (SCDA) media, in duplicate. Mark the plates indicating location and date of sampling. Let the plates solidify. Incubate them first at 30 oC to 35 oC temperature for 48 hours and then at 20 oC to 25 oC temperature for next 72 hours. Observations shall be recorded first after 48hrs and then after 120hrs. Multiply the count observed in each plate with 10, so as to get the actual count of that area. All the environmental parameters shall be verified and established at the time of installation and thereafter monitored at periodic intervals. The recommended frequencies of periodic monitoring shall be as follows: -Particulate Monitoring in Air – cont..